Cardiac Marker Testing Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Cardiac markers involve enzymes, hormones, and proteins of various forms and are used in the patients for diagnosis and risk stratification regarding chest pain and presumed acute coronary syndrome. They identify the blood level and heart functioning. These substances are released into the blood at the time when the heart is stressed or damaged, and look out for any problems such as coronary syndrome and blockage in blood flow. The measurement of these markers helps to diagnose different heart syndromes, such as acute coronary syndrome and cardiac ischemia. The cardiac marker testing provides great specificity and can help in the identification of the conditions in the early stages of presentation like troponins; they are expected to be the fastest-growing segment in the whole cardiology market.

MARKET SCOPE

The "Global Cardiac Marker Testing Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cardiac marker testing market with detailed market segmentation by product type, biomarker type, application, end user, and geography. The report provides key statistics on the market status of the leading cardiac marker testing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•  Based on product type, the global cardiac marker testing market is segmented into reagents and kits and instruments.
  
•  On the basis of biomarker type, the market is bifurcated into troponin I and T, CK-MB, BNP, myoglobin, hs-CRP and other biomarkers.
  
•  On the basis of application, the market is bifurcated into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and ischemia.
  
•  On the basis of end-users, the market is bifurcated into laboratory testing, point-of-care-testing and others.
  

MARKET DYNAMICS
Drivers

•  The rising prevalence of cardiovascular diseases and increasing geriatric population drive the global cardiac marker testing market.
  
•  Stimulating the ongoing clinical trials to identify novel cardiac markers and increased research and development activities in cardiac markers boosts the market growth.
  
•  The growing investment from public and private organizations on cardiac biomarkers fuels the market growth.
  
•  Increased healthcare expenditure and modernization of healthcare infrastructure by a larger population base propel the growth of the market.
  

Restraints

•  Factors like technical problems regarding sample collection and storage.
  
•  Issues related to regulatory and reimbursement systems.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cardiac marker testing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cardiac marker testing market in these regions.

IMPACT OF COVID-19 ON CARDIAC MARKER TESTING MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The shutdown of various plants and factories has affected the global supply chains and impacted the overall global market. The cardiac marker testing market faced a period of negative growth, which can be attributed to factors such as massive footfall in the number of patients visiting hospitals with cardiovascular conditions and those diagnosed with myocardial infarction. As strict guidelines were imposed in all areas of cardiology service hence, significant reductions can be seen in all areas, including outpatient clinics, investigations, procedures, and cardiology community services. But the increase in patient pool and relaxation in lockdown will result in the sustainable growth of the market.

Cardiac Marker Testing Market Report Analysis

Cardiac Marker Testing Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Roche Diagnostics Ltd
• Abbott Laboratories
• Siemens Healthineers AG
• Danaher Corporation
• Ortho Clinical Diagnostics
• Randox laboratories Ltd.
• bioMérieux SA
• LSI Medience Corporation
• DiaSorin S.p.A.

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Product Type

• Reagents and Kits
• Instruments

By Biomarker Type

• Troponin I and T
• CK-MB
• BillionP
• Myoglobin
• Hs-CRP
• Other Biomarkers

By Application

• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome
• Atherosclerosis
• Ischemia

By End User

• Laboratory Testing
• Point-Of-Care-Testing

MARKET PLAYERS

The report covers key developments in the cardiac marker testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from cardiac marker testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for cardiac marker testing in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the cardiac marker testing market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•  Roche Diagnostics Ltd
  
•  Abbott Laboratories
  
•  Siemens Healthineers AG
  
•  Danaher Corporation
  
•  Ortho Clinical Diagnostics
  
•  Randox laboratories Ltd.
  
•  bioMérieux SA
  
•  LSI Medience Corporation
  
•  DiaSorin S.p.A.
  
•  Bio-Rad Laboratories, Inc.
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Cardiac Marker Testing Market Report Scope